Sars CoV-2 Antibody Testing
Serological assays for SARS-CoV-2 detect the immune response of the body to the infection caused by the virus by determining the presence of antibodies in the blood rather than the virus itself. Unlike other methods which can detect the genetic material of the virus, and thus the presence of the virus, antibody tests could potentially help determine whether an individual was ever exposed to the virus, despite showing any COVID-19 symptoms or not.
Tube | red top, yellow ring. Serum sample |
---|---|
ID | 30004 |
Additional Information | At present, correlates of immunity from SARS-CoV-2 infection are not well defined. Until more data is available, positive serological assays cannot be used as indicative of existence of protective immunity against SARS-CoV-2 or as a sole-method for the diagnosis of COVID-19 disease. |
Turn Around | 5 days |
Send to | LGI Microbiology |
Collection Con | Specimens should be collected > 14 days after the onset of symptoms or a positive PCR test in asymptomatic individuals. Minimum volume 200ul |
IP Acute TAT | 5 days |
IP Routine TAT | 5 days |
GP Acute TAT | 5 days |
GP Routine TAT | 5 days |